This section is The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by Business Wire Article content
Sign In or Create an Account
or View more offersArticle content
OTTAWA, Ontario — Fullscript (the “Company”), a leading platform for practitioners delivering whole person care, today announced that L Catterton and Altas Partners (“Altas”) have agreed to acquire a majority stake in the Company from HGGC, LLC (“HGGC”) and Snapdragon Capital Partners, LLC (“Snapdragon”). The investment will help Fullscript further expand its platform and clinical support capabilities for practitioners and extend its reach across the North American healthcare market. Financial terms of the transaction were not disclosed.
Article contentWe apologize, but this video has failed to load.Try refreshing your browser, or
tap here to see other videos from our team.Article content
Story continues below
This advertisement has not loaded yet, but your article continues below.
Article content
Founded in 2011, Fullscript supports practitioners with an integrated platform providing access to data, diagnostic resources and tools they use to deliver more personalized, preventative care. Today, more than 135,000 healthcare practitioners use Fullscript to support care for 10 million patients annually across North America, with capabilities spanning evidence-based, practitioner-directed supplement recommendations and fulfillment, laboratory management, wearable health data integration and tools designed to improve patient adherence and outcomes.
Article contentArticle content
“Practitioners are at the core of our business. We have built Fullscript around a simple belief: they should have the tools and information needed to see the whole patient and deliver better care. That belief will continue to guide how we grow. Altas and L Catterton share our conviction in where healthcare is headed, and their investment and experience will help us accelerate that vision,” said Kyle Braatz, CEO and co-founder of Fullscript. “We are grateful to HGGC and Snapdragon for the invaluable support over the last five years and are excited for the next chapter ahead.”
Article content
“The convergence of conventional and functional medicine is happening at a rapid pace. Millions of Americans are seeking trusted sources of education and treatment solutions to manage chronic conditions and prevent disease in order to live their healthiest life. Practitioners require a platform that can provide trusted whole-health protocols and products that is integrated into their daily practice management and assures safety and efficacy. Fullscript does just that. We are looking forward to helping the Fullscript team continue to build the most trusted and independent brand in all of whole-health care,” said Marc Magliacano, Managing Partner at L Catterton.
Article content
“Fullscript has become integral to healthcare practitioners by building a comprehensive platform around their evolving needs. Working alongside Kyle and the team, we will leverage our relationships and operating resources to build on Fullscript’s strong momentum, deepen practitioner support, and help more patients take a proactive approach to extending their healthspan,” Rajan Shah, Partner at L Catterton, added.
Article content
“Fullscript has established itself as a clear leader in whole-person care, with an exceptional management team and a differentiated model that position the company for significant continued growth,” said Paul Emery, Partner at Altas. “We have spent considerable time studying this market and have been particularly impressed by the strength of Fullscript’s platform, the trust it has earned from practitioners, and the critical role it plays in helping them care for their patients.”
Article content
Story continues below
This advertisement has not loaded yet, but your article continues below.
Article content
Akshay Kumar, Partner at Altas, added, “We make a select number of investments each year and hold ourselves to a high bar. Fullscript is exactly the kind of exceptional company we look to partner with: a category leader with a mission-driven team and compelling growth potential. We’re excited to bring our experience supporting leading healthcare businesses to help Fullscript build on its momentum in the years ahead.”
Article content
“Over the course of our partnership, we have supported the Company’s evolution into a leading platform for practitioners delivering whole person care, including through investments in its clinical support capabilities, technology and growth initiatives,” said HGGC. “This transaction reflects the exceptional work of the Fullscript team and the meaningful value created through our partnership. We are proud of the Company’s progress and confident that Altas and L Catterton are well positioned to support Fullscript as it continues to advance its mission and pursue its next phase of growth.”
Article content
Fullscript enters this next phase with significant momentum across its platform. Most recently, University Hospitals became the latest major health system to integrate Fullscript into its Epic workflow, enabling providers to recommend clinician-grade supplements directly within the EHR. In April 2026, the Company launched Fullscript Journeys, which enables providers to deliver more personalized, consumer-grade health experiences while keeping clinical guidance at the center of care. In January 2026, Fullscript partnered with Oura to bring wearable biometric data directly into clinical workflows, giving providers a more complete view of their patients by bringing together wearable data, lab results and treatment history in one place. The Company’s 2024 acquisition of Rupa Health added advanced laboratory ordering and management tools, further expanding the breadth of the Fullscript platform.
Article content
Centerview Partners served as financial advisor to Fullscript. Evercore, Morgan Stanley & Co. LLC, and RBC Capital Markets served as financial advisors, and McDermott Will & Emery and Kirkland & Ellis served as legal counsel to both Altas and L Catterton. Jefferies LLC and William Blair served as financial advisors to HGGC and Snapdragon. The transaction is expected to close in the fourth quarter, subject to regulatory approvals and customary closing conditions.